Bigger and better: How Pfizer redefined erectile dysfunction

PLoS Medicine

Volumn 3, Issue 4, 2006, Pages 429-432

  Lexchin, Joel ^a,b,c  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

AGE DISTRIBUTION; DOSE CALCULATION; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; ERECTILE DYSFUNCTION; HEALTH SURVEY; HUMAN; LIFESTYLE; ORGANIC IMPOTENCE; PATIENT ASSESSMENT; PATIENT COUNSELING; PENIS ERECTION; PSYCHOLOGICAL ASPECT; REVIEW; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; ADOLESCENT; ADULT; ADVERTIZING; AGE; ARTICLE; DRUG COST; ECONOMICS; EVIDENCE BASED MEDICINE; INSURANCE; MALE; MIDDLE AGED; PREVALENCE; RESOURCE ALLOCATION; SEVERITY OF ILLNESS INDEX; SOCIAL STATUS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGE FACTORS; DRUG COSTS; DRUG INDUSTRY; ERECTILE DYSFUNCTION; EVIDENCE-BASED MEDICINE; HUMANS; INSURANCE COVERAGE; LIFE STYLE; MALE; MIDDLE AGED; PIPERAZINES; PREVALENCE; PURINES; RESOURCE ALLOCATION; SEVERITY OF ILLNESS INDEX; SOCIAL CONDITIONS; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 33646270867     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030132     Document Type: Review

References (16)

1. Burls A, Clark W, Gold L, Simpson S (1998) Sildenafil - An oral drug for the treatment of male erectile dysfunction. Report number 12. Birmingham (United Kingdom): West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham. 94 p.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study. J Urol 151: 54-61.
3. Longcope C, Goldfield SRW, Brambilla DJ, McKinlay J (1990) Androgens, estrogens, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 71: 1442-1446.
4. Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: Prevalence and predictors. JAMA 281: 537-544.
5. Blanker MH, Bosch JLHR, Groeneveld FPMJ, Bohnen AM, Prins A, et al. (2001) Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: Prevalence, concern, and relation to sexual activity. Urology 57: 763-768.
6. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, et al. (1999) Decline of sexual function with age in Japanese men compared with American men - Results of two community-based studies. Urology 54: 335-345.
7. Warren J (2003 December 14) In an oversexed age, more guys take a pill. New York Times. Available: http://query.nytimes.com/gst/ fullpage.html?res=9804E1DD153CF937A2575 1C1A9659C8B63&sec=health&pagewanted=1. Accessed 1 March 2006.
8. Findlay S (2000) Prescription drugs and mass media advertising. Research brief. Washington: (D. C.): National Institute for Health Care Management. Available: http://www.nihcm. org/finalweb/DTCbrief2001.pdf. Accessed 2 March 2006.
9. IMS Health (2001) Leading 10 products by U.S. DTC spend, 2000. Plymouth Meeting (Pennsylvania): Available: http://www. imshealth.com/ims/portal/front/articleC/ 0,2777,6599_40054629_1004776,00.html. Accessed 1 March 2006.
10. Yuan Y, Duckwitz N (2002) Doctors and DTCA. Pharmaceutical executive. Plymouth Meeting (Pennsylvania). Available: http://www. imshealth.com/vgn/images/portal/cit_759/ 2005112345DoctorsDTC.pdf. Accessed 1 March 2006.
11. Deer B (1998 September 6) Viagra: Sex drugs & rock 'n' roll. Sunday Times Magazine. Available: http://briandeer.com/pfizer-viagra. htm. Accessed 2 March 2006.
12. Delate T, Simmons VA, Motheral BR (2004) Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002. Int J Impot Res 16: 313-318.
13. Parens E (1998) Is better always good? The enhancement project. Hastings Cent Rep 28: S1-S16.
14. Parens E (2005) Authenticity and ambivalence. Hastings Cent Rep 35: 34-41.
15. Klein R, Sturm H (2001) Viagra: A success story for rationing? Health Aff 21: 177-187.
16. Caplan A, Elliott C (2004) Is it ethical to use enhancement technologies to make us better than well? PLoS Med 1: e52. DOI: 10.1371/journal.pmed.0010052